UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report:
(Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| None | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
Regulation S Subscription Agreement
On November 13, 2026, FDCTech, Inc. (the “Company”) entered into a Regulation S Subscription Agreement (the “Subscription Agreement”) with Quant Analytic Technologies Inc., a company organized under the laws of St. Kitts and Nevis (the “Investor”). The Investor is wholly owned by Oscar Hilt Tatum IV.
Under the Subscription Agreement, the Investor has irrevocably subscribed for shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for an aggregate subscription amount of $25,000,000 (the “Commitment”), payable in eleven installments between November 13, 2026, and September 9, 2027, in accordance with a fixed payment schedule. Each installment is priced when it is paid at $2.00 per share or, if lower, the closing price of the Common Stock on the applicable OTC Markets tier (the “Principal Market”) on the last trading day before payment, subject in all cases to a floor of $1.25 per share. The number of shares to be issued will be 12,500,000 if each installment is priced at $2.00, and up to a maximum of 20,000,000 shares if each installment is priced at the $1.25 floor. The Company’s board of directors has authorized the issuance of, and reserved, 20,000,000 authorized but unissued shares of Common Stock for issuance under the Subscription Agreement.
The shares attributable to the first two installments ($8,000,000 in the aggregate, representing up to 6,400,000 shares) will be held in a share escrow and will not be issued until the Company has received the full $25,000,000 Commitment. For each installment after the first two, the Company will cause its transfer agent to issue the corresponding shares to the Investor in book-entry form, bearing a Regulation S restrictive legend, within three business days after the later of the date the Company receives the installment in cleared funds and its scheduled payment date.
So long as the Investor beneficially owns at least 5% of the outstanding Common Stock, the Investor is entitled to nominate one individual, who must qualify as an independent director, for appointment or election to the Company’s board of directors. In addition, until the second anniversary of the signing date, and so long as the Investor and its affiliates together hold at least 4,000,000 fully paid shares, the Investor has the right to participate, on a pro rata basis, in certain future private issuances of the Company’s equity securities. The Subscription Agreement contains customary representations, warranties, covenants, indemnities and default provisions, including liquidated damages equal to 7.0% of the unfunded Commitment payable upon specified investor defaults. The Subscription Agreement is governed by the laws of the State of Delaware, and disputes are subject to arbitration under the Rules of Arbitration of the International Chamber of Commerce, seated in New York.
The foregoing description of the Subscription Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Subscription Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 3.02 Unregistered Sales of Equity Securities.
The information set forth in Item 1.01 of this Current Report under the heading “Regulation S Subscription Agreement” is incorporated by reference into this Item 3.02.
Pursuant to the Subscription Agreement described in Item 1.01, the Company has agreed to issue up to 20,000,000 shares of its Common Stock to the Investor for an aggregate subscription amount of $25,000,000, with shares issued from time to time as installments are paid at the applicable Purchase Price. The shares are being offered and sold only to a non-U.S. person in an offshore transaction in reliance on the exemption from registration provided by Regulation S under the Securities Act of 1933, as amended (the “Securities Act”). The Investor has represented that it is not a “U.S. person” within the meaning of Rule 902(k) of Regulation S and is acquiring the shares for its own account, and not for the account or benefit of any U.S. person. Neither the Company nor any person acting on its behalf has engaged in any directed selling efforts in the United States with respect to the shares. The shares have not been registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from registration. This Current Report does not constitute an offer to sell, or the solicitation of an offer to buy, any securities.
Cautionary Note Regarding Forward-Looking Statements
This Current Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the anticipated funding of, and issuance of shares under, the Subscription Agreement. These statements are based on the Company’s current expectations and are subject to risks and uncertainties, including whether the Investor funds all installments under the Subscription Agreement, and those risks described in the Company’s Annual Report on Form 10-K and its subsequent periodic reports filed with the Securities and Exchange Commission. Actual results may differ materially. Except as required by law, the Company undertakes no obligation to update any forward-looking statement.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |
| 10.1 | Regulation S Subscription Agreement, dated November 13, 2026, between FDCTech, Inc. and Quant Analytic Technologies Inc. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| Page 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| FDCTECH, INC. | |||
| November 18, 2026 | By: | /s/ Imran Firoz | |
| Date | Imran Firoz | ||
| Chief Financial Officer | |||
| (Principal Financial Officer) | |||
| Page 3 |